UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
DATE OF REPORT (Date of earliest event reported): JULY 3, 2012
000-15701
(Commission file number)
NATURAL ALTERNATIVES
INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 84-1007839 | |
| (State of incorporation) | (IRS Employer Identification No.) | |
| 1185 Linda Vista Drive San Marcos, California 92078 |
(760) 744-7340 | |
| (Address of principal executive offices) | (Registrant’s telephone number) | |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 1.01 | Entry into a Material Definitive Agreement. |
Natural Alternatives International, Inc., a Delaware corporation (“NAI”), and Abbott Laboratories (“Abbott”) have entered into an amendment (“Amendment”) to their License and Supply Agreement (“Agreement”). Under the terms of the Agreement, as previously amended, Abbott had the right to terminate the Agreement at any time up to July 31, 2012. Under the Amendment, while the due date for the payment of the remaining $354,167 of the initial installment of additional license fees remains July 31, 2012, NAI has granted Abbott an extension, until October 31, 2012, of Abbott’s termination rights. As a result, Abbott has the right to terminate the Agreement at any time before October 31, 2012 notwithstanding the payment of the initial installment amount.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Natural Alternatives International, Inc. | ||||
| Date: July 10, 2012 | By: | /s/ Ken Wolf | ||
| Ken Wolf | ||||
| Chief Financial Officer | ||||